
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Astragalus membranaceus and Salvia miltiorrhiza ameliorate diabetic kidney disease via the “gut-kidney axis”
Zhen Shen, Tao Cui, Yao Liu, et al.
Phytomedicine (2023) Vol. 121, pp. 155129-155129
Closed Access | Times Cited: 30
Zhen Shen, Tao Cui, Yao Liu, et al.
Phytomedicine (2023) Vol. 121, pp. 155129-155129
Closed Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
Targeted modulation of intestinal barrier and mucosal immune-related microbiota attenuates IgA nephropathy progression
Ran Zhang, Yuyan Tang, Xiangru Feng, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Ran Zhang, Yuyan Tang, Xiangru Feng, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Adsorption, natural attenuation, and microbial community response of ofloxacin and oxolinic acid in marine sediments
Haiping Li, Bo Zhang, Fanping Meng, et al.
Environmental Pollution (2024) Vol. 347, pp. 123738-123738
Closed Access | Times Cited: 6
Haiping Li, Bo Zhang, Fanping Meng, et al.
Environmental Pollution (2024) Vol. 347, pp. 123738-123738
Closed Access | Times Cited: 6
Kidney-tonifying blood-activating decoction delays ventricular remodeling in rats with chronic heart failure by regulating gut microbiota and metabolites and p38 mitogen-activated protein kinase/p65 nuclear factor kappa-B/aquaporin-4 signaling pathway
Rui‐Hua Xu, Yanping Bi, Xiaoteng He, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118110-118110
Closed Access | Times Cited: 6
Rui‐Hua Xu, Yanping Bi, Xiaoteng He, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118110-118110
Closed Access | Times Cited: 6
Causal relationship between gut microbiota and kidney diseases: a two-sample Mendelian randomization study
Zhoushan Feng, Yuliang Zhang, Yiyu Lai, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 5
Zhoushan Feng, Yuliang Zhang, Yiyu Lai, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 5
Hong Guo ginseng Guo (HGGG) Protects against kidney injury in Diabetic Nephropathy by Inhibiting NLRP3 Inflammasome and Regulating Intestinal Flora
Pan Shu, Shan-Shan Jiang, Rui Li, et al.
Phytomedicine (2024) Vol. 132, pp. 155861-155861
Closed Access | Times Cited: 5
Pan Shu, Shan-Shan Jiang, Rui Li, et al.
Phytomedicine (2024) Vol. 132, pp. 155861-155861
Closed Access | Times Cited: 5
Trigonella foenum-graecum L. protects against renal function decline in a mouse model of type 2 diabetic nephropathy by modulating the PI3K-Akt-ERK signaling pathway
Yang Niu, Hongjuan Niu, Liqun Chi, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Yang Niu, Hongjuan Niu, Liqun Chi, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Unlocking the potential of Radix Astragali and its active ingredients in gastric ulcer therapy
Peipei Zhang, Jin-Ling Tang, Beibei Xiang, et al.
Journal of Asian Natural Products Research (2025), pp. 1-15
Closed Access
Peipei Zhang, Jin-Ling Tang, Beibei Xiang, et al.
Journal of Asian Natural Products Research (2025), pp. 1-15
Closed Access
Integrated chemical characterization, metabolite profiling, and pharmacokinetics analysis of Zhijun Tangshen Decoction by UPLC-Q/TOF-MS
Qingheng Tong, Yueyue Chang, Guanxiong Shang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Qingheng Tong, Yueyue Chang, Guanxiong Shang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Plantaginis Semen Ameliorates Hyperuricemia Induced by Potassium Oxonate
Tian Liu, Liting Wang, Li Ji, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8548-8548
Open Access | Times Cited: 4
Tian Liu, Liting Wang, Li Ji, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8548-8548
Open Access | Times Cited: 4
Shenshuaikang enema restores the intestinal barrier and microbiota-gut-kidney axis balance to alleviate chronic kidney disease via NF-κB pathway
Ye Yan, Xiaopeng Huang, Xueying Li, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Ye Yan, Xiaopeng Huang, Xueying Li, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
The gut–kidney axis is regulated by astragaloside IV to inhibit cyclosporine A-induced nephrotoxicity
Cong Han, Ranran Gao, Le Zhou, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Cong Han, Ranran Gao, Le Zhou, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Big lessons from the little Akkermansia muciniphila in hepatocellular carcinoma
Yanguang Yang, Xinli Shi
Frontiers in Immunology (2025) Vol. 16
Open Access
Yanguang Yang, Xinli Shi
Frontiers in Immunology (2025) Vol. 16
Open Access
Huangqi and Danshen improve the chronic nephrotoxicity of Cyclosporin A by regulating lipid metabolism
Ranran Gao, Cong Han, Gui-yuan Sui, et al.
Phytomedicine (2025) Vol. 140, pp. 156582-156582
Open Access
Ranran Gao, Cong Han, Gui-yuan Sui, et al.
Phytomedicine (2025) Vol. 140, pp. 156582-156582
Open Access
Efficacy and potential pharmacological mechanism of Astragalus-Salvia miltiorrhiza combination in diabetic nephropathy: integrating meta-analysis, network pharmacology, molecular docking, and experimental validation
Huiyu Liang, Zedong Chen, Mingmin Zhu, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access
Huiyu Liang, Zedong Chen, Mingmin Zhu, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access
The gut microbiota and diabetic nephropathy: an observational study review and bidirectional Mendelian randomization study
Yi Han, Yuzhuo Wang, Xing Yu Zhu, et al.
Trials (2025) Vol. 26, Iss. 1
Open Access
Yi Han, Yuzhuo Wang, Xing Yu Zhu, et al.
Trials (2025) Vol. 26, Iss. 1
Open Access
Editorial: Gastrointestinal (GI) disorders and antioxidant therapeutics
Dipak Kumar Sahoo, G.B.N. Chainy, Albert E. Jergens
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Dipak Kumar Sahoo, G.B.N. Chainy, Albert E. Jergens
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Exploring the mechanism of Epimedium in treating diabetic nephropathy based on network pharmacology and experimental validation study
Leyu Huang, Hui Li, Ying Han
Cytotechnology (2025) Vol. 77, Iss. 3
Closed Access
Leyu Huang, Hui Li, Ying Han
Cytotechnology (2025) Vol. 77, Iss. 3
Closed Access
Gut Microbiota and Their Metabolites: The Hidden Driver of Diabetic Nephropathy? Unveiling Gut Microbe's Role in DN
J. Liu, Min Guo, Xiaobin Yuan, et al.
Journal of Diabetes (2025) Vol. 17, Iss. 4
Open Access
J. Liu, Min Guo, Xiaobin Yuan, et al.
Journal of Diabetes (2025) Vol. 17, Iss. 4
Open Access
Investigating the renoprotective effects of Polygonatum sibiricum polysaccharides (PSP) on D-galactose-induced aging mice: insights from gut microbiota and metabolomics analyses
Rui Huang, R. Che, Taoli Sun, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Rui Huang, R. Che, Taoli Sun, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Role of Gut Microbiota, Immune Imbalance, and Allostatic Load in the Occurrence and Development of Diabetic Kidney Disease
Yi Han, Hui Juan Zheng, Bo Du, et al.
Journal of Diabetes Research (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 10
Yi Han, Hui Juan Zheng, Bo Du, et al.
Journal of Diabetes Research (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 10
Intestinal flora and bile acid interactions impact the progression of diabetic kidney disease
Jia Xu, Nan Wang, Li Yang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Jia Xu, Nan Wang, Li Yang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Exploring the Impact of Optimized Probiotic Supplementation Techniques on Diabetic Nephropathy: Mechanisms and Therapeutic Potential
Anindita Ghosh, Arti Muley, Archana S Ainapure, et al.
Cureus (2024)
Open Access | Times Cited: 2
Anindita Ghosh, Arti Muley, Archana S Ainapure, et al.
Cureus (2024)
Open Access | Times Cited: 2
Artesunate Alleviates Kidney Fibrosis in Type 1 Diabetes with Periodontitis Rats via Promoting Autophagy and Suppression of Inflammation
Chen Liang, MA Licheng, Yi Chen, et al.
ACS Omega (2024) Vol. 9, Iss. 14, pp. 16358-16373
Open Access | Times Cited: 2
Chen Liang, MA Licheng, Yi Chen, et al.
ACS Omega (2024) Vol. 9, Iss. 14, pp. 16358-16373
Open Access | Times Cited: 2
Investigating the mechanism of cornel iridoid glycosides on type 2 diabetes mellitus using serum and urine metabolites in rats
Yadi Hou, Yanmei Huang, Zihui Shang, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 118065-118065
Open Access | Times Cited: 1
Yadi Hou, Yanmei Huang, Zihui Shang, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 118065-118065
Open Access | Times Cited: 1
Role of circulating inflammatory protein in the development of diabetic renal complications: proteome-wide Mendelian randomization and colocalization analyses
Wenli Liu, Jiaqi Zhang, Zhang Duo, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
Wenli Liu, Jiaqi Zhang, Zhang Duo, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1